DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.33−0.33 (-3.42%)
Close on Nov 12, 2026Market cap $503.13MP/E –Yield –
DiaMedica Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
DiaMedica Therapeutics's price to sales ratio was 79.2× on Apr 30, 2019.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Apr 30, 2019 | 79.2× | – |
See a number that looks wrong?